The Scientist - Home

The technology, tested out on patients with epilepsy who already had electrodes implanted in their brains, is currently limited to 30–50 sentences.

The machine can be run in doctor’s offices and other point-of-care settings to give rapid results.

Nine former students and faculty members who sued the institution in 2017 over its handling of sexual harassment claims will contribute a portion of the settlement to those whose careers suffered as a result.

In recent years, laboratories on the continent have ramped up genomic sequencing capabilities, offering in-country analyses rather than outsourcing the job.

Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.

Citing potential worker shortages and the effects of restricted travel and social distancing, the Environmental Protection Agency announced a “sweeping suspension” of environmental regulations that some say gives companies free rein to pollute.

Many researchers have stopped breeding mice, reduced the size of colonies, and established contingency plans in case animal care staff get sick.

Graduate students and postdocs are left wondering about the implications for their academic careers.

Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  

The small number of genetic differences between the original strain of the novel coronavirus from Wuhan and those currently circulating in the US population indicates that a vaccine may likely offer lasting immunity.

Hospitals and commercial companies are testing thousands of patients for COVID-19 daily, but face reagent and supply shortages.

A newly engineered CAR T cell that incorporates a peptide isolated from the venom of the deathstalker scorpion has broad brain tumor–binding capabilities that will be investigated in an upcoming clinical trial.